Kai Wang

Tianjin Medical University

H指数:27

被引数:2,230

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Single-Cell and Spatial Transcriptomics–Based Research Reveals Association Between M2a Macrophages and Tumor Spread through Air Spaces in Lung Adenocarcinoma

基于单细胞和空间转录组学的研究揭示了M2a巨噬细胞与肺腺癌通过空气腔隙扩散之间的关联

The American Journal of Pathology

IF0

2025-09-120

PRE

Application of Single-Cell Sequencing and Machine Learning in Prognosis and Immune Profiling of Lung Adenocarcinoma: Exploring Disease Mechanisms and Treatment Strategies Based on Circadian Rhythm Gene Signatures

单细胞测序与机器学习在肺腺癌预后与免疫图谱中的应用：基于昼夜节律基因特征探索疾病机制与治疗策略

Cancers 2025, Vol. 17, Page 2911

IF4.4

2025-09-050

OAAI

A Comprehensive Overview of the Composition, Isolation, Purification, and Biological Activities of Abalone Polysaccharides

鲍鱼多糖的组成、分离、纯化及生物活性综述

Food and Bioproducts Processing

IF3.4

2025-08-240

PRE

PD-L1-Targeting Biomimetic Photoresponsive Thermosensitive Liposomes for Triple-Negative Breast Cancer

PD-L1靶向仿生光响应温敏脂质体用于三阴性乳腺癌

Advanced Science

IF14.1

2025-08-110

Toll-Like Receptors in the Immunotherapy Era: Dual-Edged Swords of Tumor Immunity and Clinical Translation

toll-like receptors 在免疫治疗时代：肿瘤免疫与临床转化的双刃剑

MedComm

IF10.7

2025-07-270

OAAI

The glycolytic characteristics of hepatocellular carcinoma and its interaction with the microenvironment: a comprehensive omics study

肝癌细胞的糖酵解特性及其与微环境的相互作用：一项全面的组学研究

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2025-04-100

Macrophage heterogeneity and oncogenic mechanisms in lung adenocarcinoma: insights from scRNA-seq analysis and predictive modeling

FRONTIERS IN IMMUNOLOGY

IF5.9

2025-01-090

OAAI

Editorial: Epigenetic regulation of autophagy in inflammatory diseases

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-03-053

OAAI

FTO-mediated autophagy inhibition promotes non-small cell lung cancer progression by reducing the stability of SESN2 mRNA

HELIYON

IF3.6

2024-03-011

OAAI

Identifying the critical oncogenic mechanism of LDHA based on a prognostic model of T-cell synthetic drivers

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2024-01-011

PRE

Neoadjuvant chemotherapy remodels the tumor immune microenvironment by increasing activated and cytotoxic T cell, decreasing B cells and macrophages in small cell lung cancer

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2023-09-212

OAAI

Antiviral Potential of Small Molecules Cordycepin, Thymoquinone, and N6, N6-Dimethyladenosine Targeting SARS-CoV-2 Entry Protein ADAM17

MOLECULES

IF4.6

2022-12-198

OAAI

Immunomodulatory role of metalloproteases in cancers: Current progress and future trends

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-12-1620

OAAI

Whole exome sequencing in Chinese mucinous pulmonary adenocarcinoma uncovers specific genetic variations different from lung adenocarcinoma

对中国黏液性肺腺癌进行全外显子组测序，揭示了与肺腺癌不同的特定基因变异。

FRONTIERS IN ONCOLOGY

IF3.3

2022-12-151

OAAI

Immunomodulatory role of metalloproteinase ADAM17 in tumor development

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-11-1720

OAAI

Non-small-cell lung cancer patients harboring TP53/KRAS co-mutation could benefit from a PD-L1 inhibitor

TP53/KRAS共突变的非小细胞肺癌患者可从PD-L1抑制剂中获益

FUTURE ONCOLOGY

IF2.6

2022-09-066

PRE

Prognostic alternative splicing events related splicing factors define the tumor microenvironment and pharmacogenomic landscape in lung adenocarcinoma

AGING-US

IF3.9

2022-08-244

OAAI

TKI resistant-based prognostic immune related gene signature in LUAD, in which FSCN1 contributes to tumor progression

CANCER LETTERS

IF10.1

2022-04-0129

OAAI

Role of the Epigenetic Modifier JMJD6 in Tumor Development and Regulation of Immune Response

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-03-1418

OAAI

Role of NSD1 as potential therapeutic target in tumor

NSD1作为肿瘤潜在治疗靶点的作用

PHARMACOLOGICAL RESEARCH

IF10.5

2021-11-0116

PRE

Kai Wang

个人简介

教育背景

工作经历

荣誉奖项

研究方向